person · Reporting owner
Schaeffer Orlov S Nicole
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Chief People Strategy Officer | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,754 |
Ending reported balance
After 2026-01-02 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2026-01-02 · Grant · Acquired 5,293 · Balance 41,754 F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2: Each RSU was granted on January 2, 2026 for no consideration. Row 2 · 2026-01-02 · Exercise / conversion · Acquired 87,290 · Balance 129,044 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Row 3 · 2026-01-02 · Sale · Disposed 31,030 · Balance 98,014 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4: This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 4 · 2026-01-02 · Sale · Disposed 34,103 · Balance 63,911 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5: This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 5 · 2026-01-02 · Sale · Disposed 12,832 · Balance 51,079 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6: This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 6 · 2026-01-02 · Sale · Disposed 9,125 · Balance 41,954 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7: This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 7 · 2026-01-02 · Sale · Disposed 200 · Balance 41,754 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8: This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $177.12 · Expires 2036-01-02 | Direct | 27,600 |
Reported balance
After 2026-01-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-01-02 · Grant · Acquired 27,600 · Balance 27,600 F9: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.91 · Expires 2029-01-03 | Direct | 0 |
Reported balance
After 2026-01-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-01-02 · Exercise / conversion · Disposed 87,290 · Balance 0 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F2: Each RSU was granted on January 2, 2026 for no consideration.
F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F4: This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F9: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
F10: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 87,290 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · derivative · entry 9 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,290 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 27,600 | $0.00 Strike: $177.12 | $0.00 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · derivative · entry 8 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,600 Underlying: Common Stock · 27,600 shares Expires 2036-01-02 F9 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 200 | $177.78 | $35,556.00 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · nonDerivative · entry 7 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,754 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 9,125 | $177.17 | $1,616,676.25 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · nonDerivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,954 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 12,832 | $176.08 | $2,259,458.56 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,079 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 34,103 | $175.17 | $5,973,822.51 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,911 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 31,030 | $174.28 | $5,407,908.40 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,014 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 87,290 | $13.91 | $1,214,203.90 |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:03 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,293 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001401017-26-000002 · wk-form4_1767733398.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,754 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on January 2, 2026 for no consideration. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001628280-25-052361 · wk-form4_1763154773.xml · derivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,760 Underlying: Common Stock · 30,000 shares Expires 2031-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 164 | $195.88 | $32,124.32 |
DisclosureSEC source: 0001628280-25-052361 · wk-form4_1763154773.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,461 F4 · price: This is the weighted average sales price representing 164 shares sold at prices ranging from $195.42 to $195.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 19,183 | $194.44 | $3,729,942.52 |
DisclosureSEC source: 0001628280-25-052361 · wk-form4_1763154773.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,625 F3 · price: This is the weighted average sales price representing 19,183 shares sold at prices ranging from $194.02 to $194.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 6,575 | $193.64 | $1,273,183.00 |
DisclosureSEC source: 0001628280-25-052361 · wk-form4_1763154773.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,808 F2 · price: This is the weighted average sales price representing 6,575 shares sold at prices ranging from $193.02 to $194.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,078 | $192.45 | $784,811.10 |
DisclosureSEC source: 0001628280-25-052361 · wk-form4_1763154773.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,383 F1 · price: This is the weighted average sales price representing 4,078 shares sold at prices ranging from $192.00 to $192.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 30,000 | $26.46 | $793,800.00 |
DisclosureSEC source: 0001628280-25-052361 · wk-form4_1763154773.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:23 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 56,520 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001401017-25-000010 · wk-form4_1757967786.xml · derivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,520 shares Expires 2030-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:23 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 6,158 | $147.46 | $908,058.68 |
DisclosureSEC source: 0001401017-25-000010 · wk-form4_1757967786.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,461 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 6,158 shares sold at prices ranging from $147.12 to $148.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:23 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 7,304 | $146.57 | $1,070,547.28 |
DisclosureSEC source: 0001401017-25-000010 · wk-form4_1757967786.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,619 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 7,304 shares sold at prices ranging from $146.08 to $147.06 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:23 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 30,967 | $145.67 | $4,510,962.89 |
DisclosureSEC source: 0001401017-25-000010 · wk-form4_1757967786.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,923 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 30,967 shares sold at prices ranging from $145.06 to $146.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:23 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 32,091 | $144.60 | $4,640,358.60 |
DisclosureSEC source: 0001401017-25-000010 · wk-form4_1757967786.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,890 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 32,091 shares sold at prices ranging from $144.06 to $145.05 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:23 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 56,520 | $23.75 | $1,342,350.00 |
DisclosureSEC source: 0001401017-25-000010 · wk-form4_1757967786.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 20:25 UTC | INSMED Inc INSM · Entity 3174 | GiftCommon Stock | 23,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001401017-25-000007 · wk-form4_1757103943.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,461 Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 20:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 700 | $128.16 | $89,712.00 |
DisclosureSEC source: 0001401017-25-000005 · wk-form4_1755548384.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,764 F4 · price: This is the weighted average sales price representing 700 shares sold at prices ranging from $128.10 to $128.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 20:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 5,746 | $127.71 | $733,821.66 |
DisclosureSEC source: 0001401017-25-000005 · wk-form4_1755548384.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,464 F3 · price: This is the weighted average sales price representing 5,746 shares sold at prices ranging from $127.08 to $128.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 20:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 3,554 | $126.57 | $449,829.78 |
DisclosureSEC source: 0001401017-25-000005 · wk-form4_1755548384.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,210 F1 · price: This is the weighted average sales price representing 3,554 shares sold at prices ranging from $126.01 to $126.94 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F2 · balance_after: Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · derivative · entry 10 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,290 Underlying: Common Stock · 70,000 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 500 | $96.02 | $48,010.00 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 8 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,407 F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 500 shares sold at prices ranging from $96.00 to $96.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 34,500 | $95.49 | $3,294,405.00 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 7 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,907 F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 34,500 shares sold at prices ranging from $95.00 to $95.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 10,781 | $93.48 | $1,007,807.88 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,407 F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 10,781 shares sold at prices ranging from $93.20 to $93.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 18,319 | $92.73 | $1,698,720.87 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,188 F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 18,319 shares sold at prices ranging from $92.20 to $93.19 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 35,072 | $91.68 | $3,215,400.96 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,507 F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 35,072 shares sold at prices ranging from $91.18 to $92.17 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 70,000 | $13.91 | $973,700.00 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 38,300 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · derivative · entry 9 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,300 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 38,300 | $88.64 | $3,394,912.00 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,579 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:20 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 38,300 | $17.16 | $657,228.00 |
DisclosureSEC source: 0001628280-25-030969 · wk-form4_1749759622.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 20:42 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,642 | $71.50 | $117,403.00 |
DisclosureSEC source: 0001628280-25-029372 · wk-form4_1749069723.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,579 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 27,100 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026584 · wk-form4_1747688760.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,100 Underlying: Common Stock · 27,100 shares Expires 2035-05-15 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026584 · wk-form4_1747688760.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,221 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 14, 2025 Filed May 15, 2025 20:34 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,236 | $65.61 | $81,093.96 |
DisclosureSEC source: 0001628280-25-025992 · wk-form4_1747341286.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,643 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:34 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,999 | $67.81 | $338,982.19 |
DisclosureSEC source: 0001628280-25-025992 · wk-form4_1747341286.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,879 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:11 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 23,500 | $80.90 | $1,901,150.00 |
DisclosureSEC source: 0001628280-25-004464 · wk-form4_1738966294.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,878 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 23,500 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:11 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 47,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004464 · wk-form4_1738966294.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,378 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 41,140 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · derivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,140 shares Expires 2027-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $16.16 | $0.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · derivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 91,140 | $80.00 | $7,291,200.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,083 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 41,140 | $13.67 | $562,383.80 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 50,000 | $16.16 | $808,000.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 21:37 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 872 | $68.72 | $59,923.84 |
DisclosureSEC source: 0001628280-25-001733 · wk-form4_1737063455.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,083 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 3,092 | $63.62 | $196,713.04 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,955 F6 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 965 | $63.87 | $61,634.55 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,047 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.